Core Business

  

New Drug R&D

  
Website

Shanghai Bao Pharmaceuticals

Bao Pharmaceuticals Co., Ltd. focuses on the development and commercialization of recombinant protein drugs and antibody drugs. They are currently building a modern GMP compliant biopharmaceutical industrialization base with a total investment of more than RMB 900 million in Shanghai. According to the design, the base will have multiple drug substance production lines for mammalian cell expression system and Escherichia coli/yeast expression system, covering drug product lines of aqueous solution for injection, lyophilized powder for injection and pre-filled disposable injection. It is expected that the first phase of the project will be put into operation within 2 years .

Asia

News
Date Title
2023-12-05 晟德法說》釋「長線」佳音 展望明年景氣持樂觀看法 Detail
2024-06-25 晟德股東會/承認配發1.5元現金股利 殖利率3.3% 連續24年配發股利 2024年成長充滿信心 續替股東創造最大價值 Detail
2024-09-13 寶濟藥業輔助生殖創新藥物授權歐加隆 攜手搶攻中國不孕症市場 Detail